Company Overview
FIBROBIOLOGICS, INC.
FBLGRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-19M
2025 FY
Shares Outstanding
45M
2025 FY
EPS
-0.42USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1958777
Exchange
Nasdaq
Location
US